Search Saint Luke's

A secondary analysis of the pooled STEP-HFpEF and STEP-HFpEF DM trials showed the greatest improvements in those with the most weight loss at 52 weeks.

This week, Marc Roth, MD, medical director of gastrointestinal oncology at Saint Luke’s Cancer Institute and interim chief of medical oncology, is breaking down these latest advancements and what they mean for patients.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

This week during Breast Cancer Awareness Month, we’re talking about metastatic breast cancer and Saint Luke’s Koontz Center—the region’s only center dedicated and designed specifically for these patients.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.

The Kansas City Business Journal spoke to Dr. Tim Pluard about Saint Luke's Cancer Institute's expansion of services for patients battling cancer in the Northland.

KCTV talked to one local colon cancer survivor and Dr. Robert Amajoyi about the importance of screenings and when to start.